cardiac catheterization MICHAIL REGOSTA.pdf

Catheterization and Cardiovascular Interventions, 2012

*Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information. † American College of Cardiology Foundation Representative. ‡ Society for Cardiovascular Angiography and Interventions Representative. § Society of Thoracic Surgeons Representative. || Society for Vascular Medicine Representative. ¶ ACCF Task Force on Clinical Expert Consensus Documents Representative. Authors with no symbol by their names were included to provide additional content expertise apart from organizational representation This article is copublished in Circulation and Catheterization and Cardiovascular Interventions. Copies: This document is available on the World Wide Web sites of the American College of Cardiology (www.cardiosource.org), the American Heart Association (my.americanheart.org), and the Society for Cardiovascular Angiography and Interventions (www.scai.org).

Ophthalmology, 2003

Circulation, 1991

It is evident that the practice of cardiac catheterization has undergone, and continues to undergo, marked change. Most prominent are the recent very rapid proliferation of catheterization laboratories in general and the development of newer types of catheterization laboratory. No uniform definitions exist for these newer laboratories, so meaningful communication is difficult. The new settings are of particular concern because their location, mobility, organization, and ownership raise questions about the quality of patient care. Most difficult to address are the questions about patient safety and physician conflict of interest. There are no objective data in peer-reviewed literature to support the reported safety and cost savings of these newer settings. Through deliberations, surveys, interviews, and correspondence with the cardiology community embraced by the ACC and the AHA, the task force generally found that in freestanding catheterization laboratories, access to emergency hos...

Catheterization and Cardiovascular Interventions, 2012

Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information. † Society for Cardiovascular Angiography and Interventions Representative.

Primary Angioplasty, 2018

Anaesthesia, 2006

Catheterization and Cardiovascular Interventions, 2001

Journal of the American College of Cardiology, 2003

Critical Care Nurse, 2010

C ardiac catheterizations are high-risk, highvolume procedures that are performed in the United States more than 1.4 million times per year. 1 Vascular complications are the most common morbidity associated with cardiac catheterizations and have reported incidences as low as 0.1% and as high as 61%. 2,3 Most complications occur in patients who have had a percutaneous coronary intervention (PCI). 4-6 The American College of Cardiology (ACC) reported vascular complication rates of 1.7% in PCI patients. 7 Cardiac catheterization requires arterial access via a small sheath through either the femoral, brachial, or radial artery. After the sheath is removed, hemostasis is achieved at the insertion site with an internal vascular closure device or via external manual/mechanical compression.